Hugh O'Dowd, TherapeuticsMD CEO

Ther­a­peu­tic­sMD shares crater as an­tic­i­pat­ed M&A deal falls through

Six weeks af­ter an­nounc­ing an of­fer to be ac­quired for near­ly $177 mil­lion, Ther­a­peu­tic­sMD is now say­ing the deal is off.

Ex­ecs kept it short in a press re­lease, say­ing pro­posed buy­er EW Health­care Part­ners did not ac­quire the nec­es­sary shares to com­plete the deal by Tues­day night’s dead­line. The of­fer ex­pired as a re­sult, with Ther­a­peu­tic­sMD say­ing it “in­tends to main­tain nor­mal op­er­a­tions at this time.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.